Compare AU
Compare CURE vs. HACK
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Global X S&P Biotech ETF (CURE) and the BetaShares Global Cybersecurity ETF (HACK). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
CURE | HACK | |
|---|---|---|
Popularity | Low | Medium |
Pearlers invested | 82 | 1,354 |
Median incremental investment | $619.50 | $749.56 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,323.41 | $2,036.16 |
Average age group | > 35 | 26 - 35 |
Key Summary
CURE | HACK | |
|---|---|---|
Strategy | CURE.AX was created on 2018-11-08 by Global X. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index. | HACK seeks to track the performance of the NASDAQ CTA Cybersecurity Index prior to expenses and fees. |
Top 3 holdings | Natera Inc (3.41 %) Incyte Corp (2.94 %) Gilead Sciences Inc (2.88 %) | BROADCOM INC (9.09 %) INFOSYS LTD (8.80 %) CROWDSTRIKE HOLDINGS INC (8.39 %) |
Top 3 industries | Health Care (100.00 %) Other (10.24 %) | Information Technology (73.62 %) Other (17.32 %) Industrials (9.06 %) |
Top 3 countries | United States (97.17 %) Switzerland (1.51 %) United Kingdom of Great Britain and Northern Ireland (1.16 %) | United States (79.37 %) India (7.63 %) Israel (3.99 %) |
Management fee | 0.45 % | 0.67 % |
Key Summary
CURE | HACK | |
|---|---|---|
Issuer | Global X | BetaShares |
Tracking index | S&P Biotechnology Select Industry | Nasdaq CTA Cybersecurity Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.45 % | 0.67 % |
Price | $49.94 | $14.14 |
Size | $38.065 million | $1.149 billion |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 4.24 % | 4.95 % |
Market | ASX | ASX |
First listed date | 12/11/2018 | 01/09/2016 |
Purchase fee | $6.50 | $6.50 |
Community Stats
CURE | HACK | |
|---|---|---|
Popularity | Low | Medium |
Pearlers invested | 82 | 1,354 |
Median incremental investment | $619.50 | $749.56 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,323.41 | $2,036.16 |
Average age group | > 35 | 26 - 35 |
Pros and Cons
CURE | HACK | |
|---|---|---|
Pros |
|
|
Cons |
|
|
CURE | HACK |
|---|---|
Higher exposure to US market | Lower exposure to US market |
Lower management fee | Higher management fee |
Lower price growth | Higher price growth |
Lower distribution yield | Higher distribution yield |